Encouraging Improvement in Cytopenias of Patients With Myelodysplastic Syndromes With Thalidomide
ByA. Raza,L. Lisak,C. Anderews,L. Little,F. Zorat,V. Shetty,S. Alvi,S. Mundle,K. Allampallam,M. duRant,M. Ekbal,M. Muzammil
Published: | Updated:
Myelodysplastic syndrome patients present with variable cytopenias even though their bone marrows are generally hypercellular. Excessive cytokine-induced apoptosis of hematopoietic cells in the marrows has been proposed as a possible